Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens

NCT00886990 · clinicaltrials.gov ↗

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection
HIV Infections

Interventions

DRUG: ritonavir-boosted PI-based second line treatments
DRUG: two PIs boosted by low dose ritonavir or one PI plus full dose ritonavir

Sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Collaborators

[object Object]